The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions
Open accessAbstract
Tryptophan metabolites are known to participate in the regulation of many cells of the immune system and are involved in various immune-mediated diseases and disorders. Kynurenic acid (KYNA) is a product of one branch of the kynurenine pathway of tryptophan metabolism. The influence of KYNA on important neurophysiological and neuropathological processes has been comprehensively documented. In recent years, the link of KYNA to the immune system, inflammation, and cancer has become more apparent. Given this connection, the anti-inflammatory and immunosuppressive functions of KYNA are of particular interest. These characteristics might allow KYNA to act as a “double-edged sword”. The metabolite contributes to both the resolution of inflammation and the establishment of an immunosuppressive environment, which, for instance, allows for tumor immune escape. Our review provides a comprehensive update of the significant biological functions of KYNA and focuses on its immunomodulatory properties by signaling via G protein-coupled receptor 35 (GPR35)- and aryl hydrocarbon receptor-mediated pathways. Furthermore, we discuss the role of KYNA-GPR35 interaction and microbiota associated KYNA metabolism for gut homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Mitogen-activated protein kinases in innate immunity
Arthur, J. S. C., & Ley, S. C. (2013) · Nature Reviews Immunology · doi:10.1038/nri3495 · Cited by 1,855
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.009 · Cited by 952
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
The two faces of IL-6 in the tumor microenvironment
Fisher, D. T., Appenheimer, M. M., & Evans, S. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.008 · Cited by 693
Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 687
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Bessede, A., Gargaro, M., Pallotta, M. T., Matino, D., Servillo, G., Brunacci, C., Bicciato, S., Mazza, E. M. C., Macchiarulo, A., Vacca, C., et al. (2014) · Nature · doi:10.1038/nature13323 · Cited by 674
DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 634
Tryptophan metabolism, from nutrition to potential therapeutic applications
Le Floc’h, N., Otten, W., & Merlot, E. (2011) · Amino Acids · doi:10.1007/s00726-010-0752-7 · Cited by 561
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R., & Pellicciari, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Tryptophan metabolism in the central nervous system: medical implications
Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A. W., & Lowry, C. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000068 · Cited by 519
Metz, R., DuHadaway, J. B., Kamasani, U., Laury-Kleintop, L., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1872 · Cited by 467
Melatonin and Its Relation to the Immune System and Inflammation
REITER, R. J., CALVO, J. R., KARBOWNIK, M., QI, W., & TAN, D. X. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05402.x · Cited by 464
G Protein regulation of MAPK networks
Goldsmith, Z. G., & Dhanasekaran, D. N. (2007) · Oncogene · doi:10.1038/sj.onc.1210407 · Cited by 447
The kynurenine system and immunoregulation
Mándi, Y., & Vécsei, L. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0681-y · Cited by 401
The role of serotonin and its receptors in activation of immune responses and inflammation
Shajib, M. S., & Khan, W. I. (2015) · Acta Physiologica · doi:10.1111/apha.12430 · Cited by 369
Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
Platten, M., von Knebel Doeberitz, N., Oezen, I., Wick, W., & Ochs, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00673 · Cited by 340
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism
Takikawa, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.032 · Cited by 337
Aryl Hydrocarbon Receptor Control of Adaptive Immunity
Quintana, F. J., & Sherr, D. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007823 · Cited by 329
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Linderholm, K. R., Skogh, E., Olsson, S. K., Dahl, M.-L., Holtze, M., Engberg, G., Samuelsson, M., & Erhardt, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq086 · Cited by 325
Characterization of the Kynurenine Pathway in Human Neurons
Guillemin, G. J., Cullen, K. M., Lim, C. K., Smythe, G. A., Garner, B., Kapoor, V., Takikawa, O., & Brew, B. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-07.2007 · Cited by 324
Litzenburger, U. M., Opitz, C. A., Sahm, F., Rauschenbach, K. J., Trump, S., Winter, M., Ott, M., Ochs, K., Lutz, C., Liu, X., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1637 · Cited by 322
RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription
Vogel, C. F. A., Sciullo, E., Li, W., Wong, P., Lazennec, G., & Matsumura, F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0211 · Cited by 319
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
Raker, V. K., Becker, C., & Steinbrink, K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00123 · Cited by 319
Beal, M. F., Matson, W. R., Swartz, K. J., Gamache, P. H., & Bird, E. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03143.x · Cited by 311
Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.
Yoshida, R., Imanishi, J., Oku, T., Kishida, T., & Hayaishi, O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.129 · Cited by 292
Kynurenine and its metabolites in Alzheimer's disease patients
Gulaj, E., Pawlak, K., Bien, B., & Pawlak, D. (2010) · Advances in Medical Sciences · doi:10.2478/v10039-010-0023-6 · Cited by 285
Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., & Nakamura, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-8 · Cited by 273
Schefold, J. C., Zeden, J.-P., Fotopoulou, C., von Haehling, S., Pschowski, R., Hasper, D., Volk, H.-D., Schuett, C., & Reinke, P. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn739 · Cited by 251
Characterization of rat brain kynurenine aminotransferases I and II
Guidetti, P., Okuno, E., & Schwarcz, R. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971101)50:3<457::aid-jnr12>3.0.co;2-3 · Cited by 233
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230 · cited 1×
“Increased concentrations of KYNA in the brain were described in patients with Down syndrome (133), which exhibit similar neuropathological features as patients with AD, such as neuritic amyloid-β plaques (151).”
BackgroundKynurenic acid concentrations are reduced in Huntington's disease cerebral cortex
Flint Beal, M., Matson, W. R., Storey, E., Milbury, P., Ryan, E. A., Ogawa, T., & Bird, E. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90191-m · Cited by 218
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Moroni, F., Cozzi, A., Sili, M., & Mannaioni, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0763-x · Cited by 203
Cytokine Secretion in Macrophages: SNAREs, Rabs, and Membrane Trafficking
Murray, R. Z., & Stow, J. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00538 · Cited by 191
Human macrophages degrade tryptophan upon induction by interferon-gamma
Werner, E. R., Bitterlich, G., Fuchs, D., Hausen, A., Reibnegger, G., Szabo, G., Dierich, M. P., & Wachter, H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90149-4 · Cited by 189
Wehbi, V. L., & Taskén, K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00222 · Cited by 181
Sekine, H., Mimura, J., Oshima, M., Okawa, H., Kanno, J., Igarashi, K., Gonzalez, F. J., Ikuta, T., Kawajiri, K., & Fujii-Kuriyama, Y. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00337-09 · Cited by 179
The kynurenic acid hypothesis of schizophrenia
Erhardt, S., Schwieler, L., Nilsson, L., Linderholm, K., & Engberg, G. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.025 · Cited by 175
Thatcher, T. H., Maggirwar, S. B., Baglole, C. J., Lakatos, H. F., Gasiewicz, T. A., Phipps, R. P., & Sime, P. J. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060391 · Cited by 171
Two kynurenine aminotransferases in human brain
Okuno, E., Nakamura, M., & Schwarcz, R. (1991) · Brain Research · doi:10.1016/0006-8993(91)91583-m · Cited by 166
Hegde, S., Pahne, J., & Smola, S. (2004) · The FASEB Journal · doi:10.1096/fj.03-0969fje · Cited by 164
Aryl Hydrocarbon Receptor and Kynurenine: Recent Advances in Autoimmune Disease Research
Nguyen, N. T., Nakahama, T., Le, D. H., Van Son, L., Chu, H. H., & Kishimoto, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00551 · Cited by 163
Jones, S. P., Franco, N. F., Varney, B., Sundaram, G., Brown, D. A., de Bie, J., Lim, C. K., Guillemin, G. J., & Brew, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131389 · Cited by 162
Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions
Barth, M. C., Ahluwalia, N., Anderson, T. J. T., Hardy, G. J., Sinha, S., Alvarez-Cardona, J. A., Pruitt, I. E., Rhee, E. P., Colvin, R. A., & Gerszten, R. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024042 · Cited by 162
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Cruz-Haces, M., Tang, J., Acosta, G., Fernandez, J., & Shi, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0088-2 · Cited by 161
Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology
Adams, S., Teo, C., McDonald, K. L., Zinger, A., Bustamante, S., Lim, C. K., Sundaram, G., Braidy, N., Brew, B. J., & Guillemin, G. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112945 · Cited by 158
Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17
Maravillas‐Montero, J. L., Burkhardt, A. M., Hevezi, P. A., Carnevale, C. D., Smit, M. J., & Zlotnik, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401704 · Cited by 158
Taniguchi, Y., Tonai‐Kachi, H., & Shinjo, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.015 · Cited by 157
Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes
Oxenkrug, G. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9232-0 · Cited by 151
Baglole, C. J., Maggirwar, S. B., Gasiewicz, T. A., Thatcher, T. H., Phipps, R. P., & Sime, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800685200 · Cited by 151
Yang, Y., Lu, J. Y.-L., Wu, X., Summer, S., Whoriskey, J. S., Saris, C. J. M., & Reagan, J. D. (2010) · Pharmacology · doi:10.1159/000314164 · Cited by 144
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease
Hartai, Z., Juhász, A., Rimanóczy, Á., Janáky, T., Donkó, T., László, A., Penke, B., Tóth, G. K., Janka, Z., & Kalman, J. L. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.012 · Cited by 139
Kiank, C., Zeden, J.-P., Drude, S., Domańska, G., Fusch, G., Otten, W., & Schuett, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011825 · Cited by 136
Silva-García, O., Valdez-Alarcón, J. J., & Baizabal-Aguirre, V. M. (2014) · Mediators of Inflammation · doi:10.1155/2014/310183 · Cited by 132
Clarke, G. A., Fitzgerald, P., Cryan, J. F., Cassidy, E., Quigley, E. M. M., & Dinan, T. G. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-6 · Cited by 130
Fitzgerald, P., Eugene, M. C., Clarke, G. A., Scully, P., Barry, S., Eamonn, M. M. Q., Shanahan, F., Cryan, J. F., & Dinan, T. G. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01195.x · Cited by 127
Jauch, D., Urbańska, E. M., Guidetti, P., Bird, E. D., Vonsattel, J., Whetsell, W. O., & Schwarcz, R. M. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00280-2 · Cited by 127
Expression of functional GPR35 in human iNKT cells.
Fallarini, S., Magliulo, L., Paoletti, T., de Lalla, C., & Lombardi, G. (2010) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2010.06.091 · Cited by 123
Kinase AKT controls innate immune cell development and function
Zhang, Y., Wang, X., Yang, H., Liu, H., Lu, Y., Han, L., & Liu, G. (2013) · Immunology · doi:10.1111/imm.12123 · Cited by 117
Presence of kynurenic acid in food and honeybee products
Turski, M., Turska, M., Zgrajka, W., Kuc, D., & Turski, W. A. (2008) · Amino Acids · doi:10.1007/s00726-008-0031-z · Cited by 115
Kynurenine metabolism in multiple sclerosis
Hartai, Z., Klivènyi, P., Janáky, T., Penke, B., Dux, L., & Vécsei, L. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00442.x · Cited by 115
Parrott, J. M., Redus, L., & O’Connor, J. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0590-y · Cited by 112 · cited 1×
“) lipopolysaccharide (LPS) challenge increased KAT-I mRNA expression in the hippocampus 6 h postchallenge, followed by a decrease after 24 h, whereas KAT-II mRNA expression was decreased 24 h after LPS treatment (48).”
MethodJenkins, L., Brea, J. M., Smith, N. J., Hudson, B. D., Reilly, G., Bryant, N. J., Castro, M., Loza, M. I., & Milligan, G. (2010) · Biochemical Journal · doi:10.1042/bj20101287 · Cited by 110
Cooper, A. J. L. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.12.002 · Cited by 108
Altered kynurenine pathway metabolites in serum of chronic migraine patients
Curto, M., Lionetto, L., Negro, A., Capi, M., Fazio, F., Giamberardino, M. A., Simmaco, M., Nicoletti, F., & Martelletti, P. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0638-5 · Cited by 107
Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats
Stone, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05540.x · Cited by 106
pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I
Han, Q., Li, J., & Li, J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04446.x · Cited by 103
Micromolar concentration of kynurenic acid in rat small intestine
Kuc, D., Zgrajka, W., Parada-Turska, J., Urbanik‐Sypniewska, T., & Turski, W. A. (2008) · Amino Acids · doi:10.1007/s00726-007-0631-z · Cited by 103
Yü, P., Li, Z., Zhang, L., Tagle, D. A., & Cai, T. (2006) · Gene · doi:10.1016/j.gene.2005.09.034 · Cited by 102
Kynurenic Acid in the Digestive System–-New Facts, New Challenges
Turski, M. P., Turska, M., Paluszkiewicz, P., Parada-Turska, J., & Oxenkrug, G. F. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s12536 · Cited by 102
Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways
Walczak, K., Turski, W. A., & Rajtar, G. (2014) · Amino Acids · doi:10.1007/s00726-014-1790-3 · Cited by 96
Serum kynurenic acid is reduced in affective psychosis
Wurfel, B. E., Drevets, W. C., Bliss, S. A., McMillin, J. R., Suzuki, H., Ford, B. N., Morris, H. M., Teague, T. K., Dantzer, R., & Savitz, J. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.88 · Cited by 94
Chiappelli, J., Pocivavsek, A., Nugent, K. L., Notarangelo, F. M., Kochunov, P., Rowland, L. M., Schwarcz, R. M., & Hong, L. E. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.243 · Cited by 93
Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Liu, X., Newton, R., Friedman, S., & Scherle, P. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909790192374 · Cited by 92
Tiszlavicz, Z., Németh, B. C., Fülöp, F., Vécsei, L., Tápai, K., Ocsovszky, I., & Mándi, Y. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0605-2 · Cited by 91
Guo, J., Williams, D. J., Puhl, H. L., & Ikeda, S. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127266 · Cited by 86
Skene, D. J., Papagiannidou, E., Hashemi, E., Snelling, J., Lewis, D. F. V., Fernandez, M., & Ioannides, C. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.310408.x · Cited by 85
Biochemical and Structural Properties of Mouse Kynurenine Aminotransferase III
Han, Q., Robinson, H. H., Cai, T., Tagle, D. A., & Li, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01272-08 · Cited by 85
Baran, H., Cairns, N. J., Lubec, B., & Lübec, G. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00173-7 · Cited by 83
Kaszaki, J., Palásthy, Z., érczes, D., Rácz, A., Torday, C., Varga, G., Vécsei, L., & Boros, M. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00989.x · Cited by 82
Walczak, K., Dąbrowski, W., Langner, E., Zgrajka, W., Piłat, J., Kocki, T., Rzeski, W., & Turski, W. A. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.579159 · Cited by 81
Asp, L., Johansson, A., Mann, A., Owe‐Larsson, B., Urbańska, E. M., Kocki, T., Kegel, M. E., Engberg, G., Lundkvist, G. B. S., & Karlsson, H. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-25 · Cited by 81
Increased Cerebrospinal Fluid Quinolinic Acid, Kynurenic Acid, and L‐Kynurenine in Acute Septicemia
Heyes, M. P., & Lackner, A. A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08857.x · Cited by 80
Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes
Pérez‐González, A., Alvarez-Idaboy, J. R., & Galano, A. (2015) · Journal of Molecular Modeling · doi:10.1007/s00894-015-2758-2 · Cited by 77
Palmini, R. B., Masi, A., Narducci, R., Cavone, L., Maratea, D., Cozzi, A., Sili, M., Moroni, F., & Mannaioni, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082180 · Cited by 77
Liu, J., Raynal, S., Bailbé, D., Gausserès, B., Carbonne, C., Autier, V., Movassat, J., Kergoat, M., & Portha, B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.02.001 · Cited by 76
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis
Iłżecka, J., Kocki, T., Stelmasiak, Z., & Turski, W. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00076.x · Cited by 75
Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels
Mok, M. H. S., Fricker, A.-C., Weil, A., & Kew, J. N. C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.003 · Cited by 74
Altered serum levels of kynurenine metabolites in patients affected by cluster headache
Curto, M., Lionetto, L., Negro, A., Capi, M., Perugino, F., Fazio, F., Giamberardino, M. A., Simmaco, M., Nicoletti, F., & Martelletti, P. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0620-2 · Cited by 74
Anderson, G., & Maes, M. H. J. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691738 · Cited by 74
Wirthgen, E., & Hoeflich, A. (2015) · Journal of Amino Acids · doi:10.1155/2015/973548 · Cited by 73
Self-citationKynurenic acid downregulates IL-17/1L-23 axis in vitro
Elizei, S. S., Poormasjedi‐Meibod, M., Wang, X., Kheirandish, M., & Ghahary, A. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-2975-3 · Cited by 73
Arnáiz‐Cot, J. J., Gonzalez, J., Sobrado, M., Baldelli, P., Carbone, E., Gandía, L., García, A. G., & Hernández-Guijo, J. M. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06077.x · Cited by 69
Forrest, C. M., Gould, S. R., Darlington, L. G., & Stone, T. W. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_46 · Cited by 69
García‐Lara, L., Pérez‐Severiano, F., González‐Esquivel, D. F., Elizondo, G., & Segovia, J. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23595 · Cited by 64
Zeden, J.-P., Fusch, G., Holtfreter, B., Schefold, J. C., Reinke, P., Domańska, G., Haas, J., Gruendling, M., Westerholt, A., & Schuett, C. (2010) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1003800213 · Cited by 64
Alternative kynurenic acid synthesis routes studied in the rat cerebellum
Ayala, T. B., Lugo-Huitrón, R., Carmona‐Aparicio, L., Ortega, D. R., González‐Esquivel, D. F., Pedraza‐Chaverrí, J., de la Cruz, G. P., Ríos, C., Schwarcz, R. M., & de la Cruz, V. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00178 · Cited by 60
Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells
Walczak, K., Deneka-Hannemann, S., Jarosz, B., Zgrajka, W., Stoma, F., Trojanowski, T., Turski, W. A., & Rzeski, W. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.06.007 · Cited by 59
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
Majláth, Z., Török, N., Toldi, J., & Vécsei, L. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151113123221 · Cited by 59
Wennström, M., Nielsen, H. M., Orhan, F., Londos, E., Minthon, L., & Erhardt, S. (2014) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s13958 · Cited by 58
Han, C., Chen, T., Yang, M., Li, N., Liu, H., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802002 · Cited by 56
Szymona, K., Zdzisińska, B., Karakuła‐Juchnowicz, H., Kocki, T., Kandefer‐Szerszeń, M., Flis, M., Rosa, W., & Urbańska, E. M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9714-0 · Cited by 56
Gkotsos, G., Virgiliou, C., Lagoudaki, I., Sardeli, C., Raikos, Ν., Theodoridis, G. A., & Dimitriadis, G. P. (2017) · Metabolites · doi:10.3390/metabo7010009 · Cited by 55
Walczak, K., Żurawska, M., Kiś, J., Starownik, R., Zgrajka, W., Bar, K., Turski, W. A., & Rzeski, W. (2012) · Amino Acids · doi:10.1007/s00726-012-1247-5 · Cited by 54
Microbial oxidation of kynurenic, xanthurenic and picolinic acids
Dagley, S., & Johnson, P. A. (1963) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(63)91023-0 · Cited by 52
Zhang, S., Patel, A., Chu, C., Jiang, W., Wang, L., Welty, S. E., Moorthy, B., & Shivanna, B. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.023 · Cited by 52
Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model
Wirthgen, E., Tuchscherer, M., Otten, W., Domańska, G., Wollenhaupt, K., Tuchscherer, A., & Kanitz, E. (2013) · Innate Immunity · doi:10.1177/1753425913481252 · Cited by 52
Self-citationShevtsov, S. P., Haq, S., & Force, T. L. (2006) · Cell Cycle · doi:10.4161/cc.5.20.3357 · Cited by 49
Dobelis, P., Staley, K. J., & Cooper, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041108 · Cited by 49
High concentration of kynurenic acid in bile and pancreatic juice
Paluszkiewicz, P., Zgrajka, W., Saran, T., et al. (2008) · Amino Acids · doi:10.1007/s00726-008-0183-x · Cited by 48
Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome
Christmas, D. M., Badawy, A. A. ‐., Hince, D., Davies, S., Probert, C. S., Creed, T., Smithson, J., Afzal, M., Nutt, D., & Potokar, J. P. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.09.009 · Cited by 48
Endogenous ligands of the aryl hydrocarbon receptor regulate lung dendritic cell function
Thatcher, T. H., Williams, M. A., Pollock, S. J., McCarthy, C. E., Lacy, S. H., Phipps, R. P., & Sime, P. J. (2015) · Immunology · doi:10.1111/imm.12540 · Cited by 48
Stążka, J., Luchowski, P., Wielosz, M., Kleinrok, Z., & Urbańska, E. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01943-x · Cited by 46
Parada-Turska, J., Rzeski, W., Zgrajka, W., Majdan, M., Kandefer‐Szerszeń, M., & Turski, W. A. (2005) · Rheumatology International · doi:10.1007/s00296-005-0057-4 · Cited by 46
Igari, T., Tsuchizawa, M., & Shimamura, T. (1987) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.153.79 · Cited by 43
Schubart, U. K. (1986) · Endocrinology · doi:10.1210/endo-119-4-1741 · Cited by 43
Kynurenic acid enhances expression of p21 Waf1/Cip1 in colon cancer HT-29 cells
Walczak, K., Turski, W. A., & Rzeski, W. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70870-8 · Cited by 35
Kynurenic acid in human saliva--does it influence oral microflora?
Kuc, D., Rahnama, M., Tomaszewski, T., Rzeski, W., Wejksza, K., Urbanik‐Sypniewska, T., Parada-Turska, J., Wielosz, M., & Turski, W. A. (2006) · PubMed · Cited by 35
Aryl hydrocarbon receptor ligand effects in RBL2H3 cells
Maaetoft‐Udsen, K., Shimoda, L. M. N., Frøkiær, H., & Turner, H. C. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.661802 · Cited by 34
Vécsei, L., & Beal, M. F. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90123-h · Cited by 33
Effect of kynurenic acid on the viability of probiotics in vitro
Czopska-Dolecka, J., Urbanik‐Sypniewska, T., Skrzydło-Radomańska, B., & Parada-Turska, J. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70522-9 · Cited by 33
Małaczewska, J., Siwicki, A. K., Wójcik, R., Turski, W. A., & Kaczorek‐Łukowska, E. (2016) · Central European Journal of Immunology · doi:10.5114/ceji.2016.58815 · Cited by 33
Fotopoulou, C., Sehouli, J., Pschowski, R., von Haehling, S., Domańska, G., Braicu, E. I., Fusch, G., Reinke, P., & Schefold, J. C. (2011) · PubMed · Cited by 32
Indole-3-Pyruvic Acid as a Direct Precursor of Kynurenic Acid
Politi, V., Lavaggi, M. V., Stazio, G. D., & Margonelli, A. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5952-4_57 · Cited by 31
Dąbrowski, W., Kocki, T., Piłat, J., Parada-Turska, J., & Malbrain, M. L. N. G. (2013) · Inflammation · doi:10.1007/s10753-013-9733-9 · Cited by 30
Yang, I.-H., Wong, J.-H., Chang, C., Chen, B.-K., Tsai, Y.-T., Chen, W.-C., Wang, E. T., Hsu, W.-L., & Chang, W. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15299 · Cited by 30
Steiner, L., Gold, M., Mengel, D., Dodel, R. C., & Bach, J. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.06.032 · Cited by 29
Studies on the Metabolism of Kynurenic Acid
Hayaishi, O., Taniuchi, H., Tashiro, M., & Kuno, S. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64026-8 · Cited by 29
Kynurenic acid actions in brain and periphery
Moroni, F., Fossati, S., Chiarugi, A., & Cozzi, A. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.016 · Cited by 27
Melatonin and Elimination of Kynurenines in Children with Down's Syndrome
Uberos, J., Romero, J. L. C., Molina‐Carballo, A., & Muñoz‐Hoyos, A. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.23.3.277 · Cited by 27
Arvidson, N. G., Larsson, A., & Larsen, A. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102760145889 · Cited by 21
Lee, K., Jung, K., Cho, J., Lee, S., Kim, H. S., Shim, J. H., Lee, S. K., Kim, M., & Chu, K. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.3.132 · Cited by 12
Sagan, D., Kocki, T., Patel, S., & Kocki, J. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.7541 · Cited by 11
Isenović, E. R., Žakula, Z., Korićanac, G., & Stepić, N. (2008) · Physiological Research · doi:10.33549/physiolres.931135 · Cited by 9
Cited by
The kynurenine pathway: a finger in every pie
Savitz, J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0414-4 · Cited by 756
Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?
Ostapiuk, A., & Urbanska, E. M. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13768 · Cited by 142
Grishanova, A. Y., & Perepechaeva, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126719 · Cited by 130
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
Li, D., Yu, S., Long, Y., Shi, A., Deng, J., Ma, Y., Wen, J., Li, X., Liu, S., Zhang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985378 · Cited by 129
Healthy aging and muscle function are positively associated with NAD+ abundance in humans
Janssens, G. E., Grevendonk, L., Perez, R. Z., Schomakers, B. V., de Vogel-van den Bosch, J., Geurts, J. M. W., van Weeghel, M., Schrauwen, P., Houtkooper, R. H., & Hoeks, J. (2022) · Nature Aging · doi:10.1038/s43587-022-00174-3 · Cited by 103
Metadata
- Authors
- Wirthgen, E., Hoeflich, A., Rebl, A., & Günther, J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-01-10
- Volume
- 8
- Pages
- 1957-1957
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2783132192
- Cited by
- 378
- References
- 145
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.